Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and pharmaceutical compositions for the treatment of diseases mediated by the NRP-1/OBR complex signaling pathway

Methods and pharmaceutical compositions for the treatment of diseases mediated by the NRP-1/OBR complex signaling pathway

US Patent 11629192 · Granted Apr 18, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Masitinib for the treatment of sickle cell disease2025
Method for determining the invasive potential of a tumor cell2024
Methods and pharmaceutical compositions for the treatment of mast cell diseases2022
Methods and pharmaceutical compositions for the treatment of systemic mastocytos2021
Polypeptides capable of inhibiting the binding between leptin and Neuropilin-12020
Polypeptides capable of inhibiting the binding between leptin and Neuropilin-12020
Polypeptides capable of inhibiting the binding between leptin and Neuropilin-12020
Polypeptides capable of inhibiting the binding between leptin and Neuropilin-12020
Use of hydroxycarbamide for preventing retinal nonperfusion2020
Synthetic lethal drug combination for treating renal cell carcinoma2019
Methods for determining the risk of acute graft versus host disease2018
Composition comprising a combination of DNA methylation inhibitor and a vitamin 2018